You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ocular Graft vs Host Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular

Withdrawn
  • Graft Vs Host Disease
  • DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
  • Regular dissolvable intracanalicular plug
  • Boston, Massachusetts
    Mass Eye and Ear
Dec 14, 2021

Ocular GVHD, Dry Eye Trial in Chicago (rhDNase I, Vehicle)

Terminated
Has Results
  • Ocular Graft vs Host Disease
  • Dry Eye
  • Chicago, Illinois
  • +1 more
Aug 10, 2021

Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients

Recruiting
  • Ocular GVHD
    • Indianapolis, Indiana
      Glick Eye Institute - Indiana University
    Sep 2, 2021

    2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface

    Recruiting
    • Dry Eye Disease
    • oGVHD
    • The standard care exam and biological specimens' collection
    • Baltimore, Maryland
      Geenebaum Cancer Center, University of Maryland Medical Center
    Jun 2, 2022

    Graft-versus-host-disease, Ocular Graft-versus-host Disease Trial in Bellaire (Lifitegrast 5% Ophthalmic Solution, Refresh)

    Not yet recruiting
    • Graft-versus-host-disease
    • Ocular Graft-versus-host Disease
    • Lifitegrast 5% Ophthalmic Solution
    • Refresh
    • Bellaire, Texas
      Richard W Yee, MD PLLC
    Apr 27, 2022

    Ocular Surface Disease in Chronic Graft-Versus-Host Disease

    Recruiting
    • Dry Eye
    • GVHD
    • Cross-sectional study
    • Singapore, Singapore
      Cynthia Boo
    Mar 22, 2022

    Ocular Graft-versus-host Disease Trial in Saint-Petersburg (Allogeneic platelet lysate eye drops)

    Recruiting
    • Ocular Graft-versus-host Disease
    • Allogeneic platelet lysate eye drops
    • Saint-Petersburg, Russian Federation
      First Pavlov State Medical University of St. Petersburg
    Apr 4, 2022

    Ocular Graft-versus-host Disease Trial in Saint Louis (Vigamox, Placebo)

    Recruiting
    • Ocular Graft-versus-host Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 12, 2022

    Ocular Graft-versus-host Disease Trial in Needham (Pro-ocular™ Topical Gel 1%, Placebo)

    Recruiting
    • Ocular Graft-versus-host Disease
    • Pro-ocular™ Topical Gel 1%
    • Placebo
    • Needham, Massachusetts
      BostonSight
    Dec 1, 2021

    GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)

    Completed
    • Graft Versus Host Disease in Eye
    • Beijing, Beijing, China
      Peking University Third Hospital
    Mar 14, 2022

    Graft Vs Host Disease, Haematological Malignancy, Cancer Trial in Hong Kong

    Recruiting
    • Graft Vs Host Disease
    • +2 more
      • Hong Kong, Hong Kong
        Department of Ophthalmology, LKS Faculty of Medicine, The Univer
      Dec 9, 2021

      Dry Eye, Graft-versus-host-disease, Ocular Discomfort Trial in United States (CAM-101 10%, Vehicle Control, CAM-101 30%)

      Completed
      • Dry Eye
      • +2 more
      • CAM-101 10%
      • +2 more
      • Palo Alto, California
      • +5 more
      Jul 26, 2021

      Chronic Ocular Graft-versus-host Disease Trial in Boston (Pro-ocular™ topical gel, Placebo topical gel)

      Active, not recruiting
      • Chronic Ocular Graft-versus-host Disease
      • Pro-ocular™ topical gel
      • Placebo topical gel
      • Boston, Massachusetts
        Massachusetts Eye and Ear Longwood
      Mar 12, 2021

      Ocular GVHD Trial in Salt Lake City (Amniotic Fluid Eye Drops (AFED), Saline Solution)

      Recruiting
      • Ocular Graft Versus Host Disease
      • Amniotic Fluid Eye Drops (AFED)
      • Saline Solution
      • Salt Lake City, Utah
        University of Utah Huntsman Cancer Institute
      Feb 3, 2021

      Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

      Not yet recruiting
      • Graft Vs Host Disease
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 18, 2023

      Graft-versus-host-disease, CMV Trial (Letermovir)

      Not yet recruiting
      • Graft-versus-host-disease
      • CMV
      • (no location specified)
      Jul 23, 2023

      Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

      Completed
      • Steroid Refractory GVHD
      • Taoyuan, Taiwan
        Chang Gung Memorial Hospital
      Dec 15, 2022

      Patients at Risk for Chronic Graft-Versus-Host Disease

      Not yet recruiting
      • cGVHD
      • Non-Interventional
      • (no location specified)
      Jun 16, 2023

      Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

      Not yet recruiting
      • Acute Graft Versus Host Disease
      • Hematopoietic and Lymphoid System Neoplasm
      • Fecal Microbiota Transplantation Capsule
      • Placebo
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 6, 2023

      Chronic GVHD Trial in United States (drug, procedure, other)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • Tampa, Florida
      • +4 more
      Aug 10, 2023

      Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

      Not yet recruiting
      • Steroid-refractory Acute Graft-versus-host Disease
      • MC0518
      • BAT
      • (no location specified)
      Oct 4, 2023

      Acute GVHD Trial (Itolizumab, Methylprednisolone)

      Not yet recruiting
      • Acute Graft Versus Host Disease
      • (no location specified)
      Apr 10, 2023

      Evaluation of the Impact of Reduced Immunosuppression

      Enrolling by invitation
      • Graft Vs Host Disease
      • Dallas, Texas
        Methodist Dallas Medical Center
      Dec 20, 2022

      A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

      Not yet recruiting
      • Graft-versus-Host Disease
      • ruxolitinib
      • (no location specified)
      Jan 11, 2023

      Chronic Graft Vs. Host Disease Trial (INCA34176)

      Available
      • Chronic Graft Vs. Host Disease
      • (no location specified)
      Sep 14, 2022